Hepatitis C virus in the human liver transplantation model (Q35105697)

6 August 2017

1 reference

title

Hepatitis C virus in the human liver transplantation model (English)

1 reference

6 August 2017

liver transplantation

1 reference

1 reference

Hugo R. Rosen

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12691461

23 December 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=12691461

23 December 2023

publication date

1 February 2003

1 reference

full work available at URL

6 August 2017

https://api.elsevier.com/content/article/PII:S1089326102000739?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S1089-3261(02)00073-9

https://api.elsevier.com/content/article/PII:S1089326102000739?httpAccept=text/plain

23 December 2023

1 reference

https://api.crossref.org/works/10.1016/S1089-3261(02)00073-9

23 December 2023

published in

Clinics in liver disease

1 reference

6 August 2017

7

1 reference

6 August 2017

1

1 reference

6 August 2017

107-125

1 reference

The Nineteenth United States-Japan Joint Hepatitis Panel Meeting

6 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900073-9

7 January 2021

Steatosis and liver cancer in transgenic mice expressing the structural and nonstructural proteins of hepatitis C virus

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900073-9

7 January 2021

The association between hepatitis C infection and survival after orthotopic liver transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900073-9

7 January 2021

Long-term outcome of hepatitis C infection after liver transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900073-9

7 January 2021

Predictors of patient and graft survival following liver transplantation for hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900073-9

7 January 2021

A pilot study of the tolerability and efficacy of antiviral therapy in hepatitis C virus-infected patients awaiting liver transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900073-9

7 January 2021

Treatment of progressive hepatitis C recurrence after liver transplantation with combination interferon plus ribavirin

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900073-9

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900073-9

7 January 2021

Natural history of clinically compensated hepatitis C virus-related graft cirrhosis after liver transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900073-9

7 January 2021

Hepatitis C infection in patients undergoing liver retransplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900073-9

7 January 2021

Adult-to-adult transplantation of the right hepatic lobe from a living donor

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900073-9

7 January 2021

T-cell clones derived by CD3 stimulation from hepatitis C virus explanted liver tissue are not representative of dominant clones present in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900073-9

7 January 2021

Hepatitis C virus proteins: direct link to hepatic oxidative stress, steatosis, carcinogenesis and more

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900073-9

7 January 2021

Quantitation of hepatitis C virus RNA in liver transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900073-9

7 January 2021

Hepatitis C virus kinetics during and immediately after liver transplantation.

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900073-9

7 January 2021

Exposure of hepatitis C virus (HCV) RNA-positive recipients to HCV RNA-positive blood donors results in rapid predominance of a single donor strain and exclusion and/or suppression of the recipient strain

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900073-9

7 January 2021

Hepatitis C quasispecies and severity of recurrence: cause, consequence, or coincidence?

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900073-9

7 January 2021

Will transplantation of an hepatitis C-infected graft improve the outcome of liver transplantation in HCV patients?

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900073-9

7 January 2021

Outcome of liver transplantation in hepatitis C virus-infected patients who received hepatitis C virus-infected grafts

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900073-9

7 January 2021

Quasispecies of hepatitis C virus in serum and in three different parts of the liver of patients with chronic hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900073-9

7 January 2021

Tracking hepatitis C virus quasispecies major and minor variants in symptomatic and asymptomatic liver transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900073-9

7 January 2021

Post-transplant quasispecies pattern remains stable over time in patients with recurrent cholestatic hepatitis due to hepatitis C virus

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900073-9

7 January 2021

Evolution of hepatitis C virus quasispecies in patients with severe cholestatic hepatitis after liver transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900073-9

7 January 2021

Is the quasispecies concept relevant to RNA viruses?

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900073-9

7 January 2021

A longitudinal analysis of T-cell epitope-coding regions of hepatitis C virus after liver transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900073-9

7 January 2021

Genetic Clustering of Hepatitis C Virus Strains and Severity of Recurrent Hepatitis after Liver Transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900073-9

7 January 2021

Innate and adaptive lymphoid cells in the human liver

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900073-9

7 January 2021

Inhibition of Natural Killer Cells through Engagement of CD81 by the Major Hepatitis C Virus Envelope Protein

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900073-9

7 January 2021

Binding of the Hepatitis C Virus Envelope Protein E2 to CD81 Inhibits Natural Killer Cell Functions

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900073-9

7 January 2021

Decrease of CD56(+)T cells and natural killer cells in cirrhotic livers with hepatitis C may be involved in their susceptibility to hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900073-9

7 January 2021

Decrease in hepatic CD56(+) T cells and V alpha 24(+) natural killer T cells in chronic hepatitis C viral infection.

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900073-9

7 January 2021

OKT3 and hepatitis C: defining the risks

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900073-9

7 January 2021

Anti-interleukin-2 receptor therapy in combination with mycophenolate mofetil is associated with more severe hepatitis C recurrence after liver transplantation.

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900073-9

7 January 2021

Cytomegalovirus viremia: risk factor for allograft cirrhosis after liver transplantation for hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900073-9

7 January 2021

Association of multispecific CD4(+) response to hepatitis C and severity of recurrence after liver transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900073-9

7 January 2021

Hepatitis C virus-specific CD4+ T cell response after liver transplantation occurs early, is multispecific, compartmentalizes to the liver, and does not correlate with recurrent disease

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900073-9

7 January 2021

Frequencies of HCV-specific effector CD4+ T cells by flow cytometry: correlation with clinical disease stages

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900073-9

7 January 2021

Intrahepatic cytokine profiles associated with posttransplantation hepatitis C virus-related liver injury.

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900073-9

7 January 2021

Timing of reinfection and mechanisms of hepatocellular damage in transplanted hepatitis C virus-reinfected liver

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900073-9

7 January 2021

Immunology. A perfect mismatch

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900073-9

7 January 2021

Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900073-9

7 January 2021

Corticosteroids prevent generation of CD34+-derived dermal dendritic cells but do not inhibit Langerhans cell development

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900073-9

7 January 2021

Donor polymorphism of tumor necrosis factor gene: relationship with variable severity of hepatitis C recurrence after liver transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900073-9

7 January 2021

Noncytolytic control of viral infections by the innate and adaptive immune response

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900073-9

7 January 2021

Persistent hepatitis C virus infection after liver transplantation: clinical and virological features

series ordinal

17

1 reference

https://api.crossref.org/works/10.1016/S1089-3261(02)00073-9

Modulation of hepatitis B viral antigen expression by immunosuppressive drugs in primary hepatocyte culture

23 December 2023

series ordinal

38

1 reference

https://api.crossref.org/works/10.1016/S1089-3261(02)00073-9

23 December 2023

Identifiers

1 reference

6 August 2017

1 reference